This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (162) Opioid and Related Substance Misuse (128) Substance Abuse (383) HIV/AIDS/STI Prevention and Care (823)

Published on in Vol 11, No 10 (2022): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/42585, first published .
Nurse Practitioner–Led Integrated Rapid Access to HIV Prevention for People Who Inject Drugs (iRaPID): Protocol for a Pilot Randomized Controlled Trial

Nurse Practitioner–Led Integrated Rapid Access to HIV Prevention for People Who Inject Drugs (iRaPID): Protocol for a Pilot Randomized Controlled Trial

Nurse Practitioner–Led Integrated Rapid Access to HIV Prevention for People Who Inject Drugs (iRaPID): Protocol for a Pilot Randomized Controlled Trial

Authors of this article:

Antoine Khati1 Author Orcid Image ;   Frederick L Altice2 Author Orcid Image ;   David Vlahov3 Author Orcid Image ;   William H Eger2 Author Orcid Image ;   Jessica Lee2 Author Orcid Image ;   Terry Bohonnon2 Author Orcid Image ;   Jeffrey A Wickersham2 Author Orcid Image ;   Francesca Maviglia2 Author Orcid Image ;   Nicholas Copenhaver1 Author Orcid Image ;   Roman Shrestha1, 2 Author Orcid Image
Article Authors Cited by (1) Tweetations (9) Metrics

Journals

  1. Corneli A, Perry B, Des Marais A, Choi Y, Chen H, Lilly R, Ayers D, Bennett J, Kestner L, Meade C, Sachdeva N, McKellar M. Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation. Harm Reduction Journal 2022;19(1) View